- 1. Second Clinical College of Shandong University, Jinan, Shandong 250012, P. R. China;
- 2. Gastrointestinal Surgery Department, Second Hospital of Shandong University, Jinan, Shandong 250012, P. R. China;
With the swift evolution of bariatric and metabolic surgery, additional procedures building upon sleeve gastrectomy have consistently surfaced. Recent studies suggest that sleeve gastrectomy with jejunojejunal bypass (SG-JJB) yields superior short-term weight reduction outcomes compared to sleeve gastrectomy alone, with weight loss and glycemic control effects akin to Roux-en-Y gastric bypass, and without significant complications. As a result, SG-JJB is regarded as a safe and efficacious bariatric procedure, noted for its technical simplicity and reversibility, presenting substantial clinical utility. Nonetheless, high-quality, multicenter, large-sample, long-term follow-up randomized controlled trials are essential to further ascertain its long-term efficacy and safety, and to facilitate its standardized implementation. This article seeks to review the advancements in SG-JJB research, evaluate its effectiveness and safety in managing obesity and associated comorbidities, and explore its future developmental trajectory.
Citation: WANG Lang, DING Yinlu. Research progress of sleeve gastrectomy with jejunojejunal bypass. West China Medical Journal, 2025, 40(2): 305-312. doi: 10.7507/1002-0179.202407321 Copy
Copyright © the editorial department of West China Medical Journal of West China Medical Publisher. All rights reserved
1. | Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism, 2022, 133: 155217. |
2. | NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet, 2024, 403(10431): 1027-1050. |
3. | Okunogbe A, Nugent R, Spencer G, et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health, 2022, 7(9): e009773. |
4. | GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2162-2203. |
5. | Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery?. Pharmacol Ther, 2023, 251: 108549. |
6. | Brown WA, Liem R, Al-Sabah S, et al. Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report. Obes Surg, 2024, 34(5): 1764-1777. |
7. | Biter LU, ’t Hart JW, Noordman BJ, et al. Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase Ⅲ multicentre randomised controlled trial (SleeveBypass). Lancet Reg Health Eur, 2024, 38: 100836. |
8. | Dang JT, Vaughan T, Mocanu V, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications, prevalence, and safety. Obes Surg, 2023, 33(5): 1486-1493. |
9. | Nielsen HJ, Nedrebø BG, Fosså A, et al. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obes (Lond), 2022, 46(4): 739-749. |
10. | Kim JC, Kim MG, Park JK, et al. Outcomes and adverse events after bariatric surgery: an updated systematic review and meta-analysis, 2013-2023. J Metab Bariatr Surg, 2023, 12(2): 76-88. |
11. | 王涛, 师振, 于飞. 不同手术方案治疗重度肥胖合并 2 型糖尿病疗效比较. 新乡医学院学报, 2022, 39(4): 371-375. |
12. | Huang CK, Mahendra R, Hsin MC, et al. Novel metabolic surgery: first Asia series and short-term results of laparoscopic proximal jejunal bypass with sleeve gastrectomy. Ann Laparosc Endosc Surg, 2016, 1: 37. |
13. | 李梦伊, 刘雁军, 王桂琦, 等. 大中华减重与代谢手术数据库 2023 年度报告. 中国实用外科杂志, 2024, 44(5): 552-563, 570. |
14. | 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2023 年度报告. 中华肥胖与代谢病电子杂志, 2024, 10(2): 73-83. |
15. | Lin S, Li C, Guan W, et al. Three-year outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective case-matched study with sleeve gastrectomy and gastric bypass in Chinese patients with BMI ≥35 kg/m2. Obes Surg, 2021, 31(8): 3525-3530. |
16. | Alamo Alamo M, Sepúlveda Torres C, Zapata Perez L. Vertical isolated gastroplasty with gastro-enteral bypass: preliminary results. Obes Surg, 2006, 16(3): 353-358. |
17. | de Menezes Ettinger JE, Azaro E, Mello CA, et al. Analysis of the vertical isolated gastroplasty: a new bariatric operation. Obes Surg, 2006, 16(9): 1261-1263. |
18. | Alamo M, Sepúlveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index <35 kg/m2. A cohort study. Obes Surg, 2012, 22(7): 1097-1103. |
19. | 梁辉. 袖状胃切除加空肠旷置术的研究现状. 中华胃肠外科杂志, 2022, 25(10): 886-891. |
20. | Sridhar A, Khan D, Abdelaal M, et al. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats. PLoS One, 2022, 17(9): e0274788. |
21. | 罗衡桂, 唐彬, 毛岳峰, 等. 不同类型减重代谢手术治疗重度肥胖合并 2 型糖尿病的近期疗效分析. 中国普通外科杂志, 2020, 29(10): 1224-1233. |
22. | 梁辉, 李聪, 林士波, 等. 胃袖状切除术联合近端空肠旁路术与 Roux-en-Y 胃旁路术治疗 2 型糖尿病对照研究. 中国实用外科杂志, 2023, 43(5): 557-561. |
23. | 梁辉, 李聪, 沈佳佳. 胃袖状切除术附加手术术式选择及难点. 中国实用外科杂志, 2023, 43(5): 529-533. |
24. | Liang L, Gu R, Zheng R, et al. Comparative study of laparoscopic sleeve gastrectomy with or without jejunal bypass. Obes Surg, 2024, 34(8): 2888-2896. |
25. | 郑锐滨, 周霞, 赵象文. 超级肥胖的手术选择: 袖状胃切除术+空肠空肠旁路术?. 腹腔镜外科杂志, 2023, 28(10): 727-732. |
26. | 中国人体健康科技促进会肥胖糖尿病主动健康专业委员会. 中国对称三孔法腹腔镜胃袖状切除术规范化手术操作指南(2023 版). 华西医学, 2023, 38(12): 1785-1791. |
27. | Lin S, Guan W, Yang N, et al. Short-term outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective comparative study with sleeve gastrectomy and Roux-en-Y gastric bypass in Chinese patients with BMI ≥ 35 kg/m2. Obes Surg, 2019, 29(4): 1352-1359. |
28. | Sepúlveda M, Alamo M, Preiss Y, et al. Metabolic surgery comparing sleeve gastrectomy with jejunal bypass and Roux-en-Y gastric bypass in type 2 diabetic patients after 3 years. Obes Surg, 2018, 28(11): 3466-3473. |
29. | 刘山, 刘国栋, 胡鹏飞, 等. 中度肥胖患者行袖状胃切除与袖状胃切除联合空肠旁路术的短期效果对比分析. 腹腔镜外科杂志, 2023, 28(9): 664-669. |
30. | 刘浩, 赵稳, 武现生, 等. 40 kg/m2≤体重指数≤50 kg/m2 肥胖病人胃袖状切除联合空肠-空肠旁路术疗效的 2 年随访分析. 腹部外科, 2023, 36(5): 348-354. |
31. | 赵象文, 刘彦章, 梁銮盛, 等. 胃袖状切除加空肠旁路术在肥胖症的初步应用. 中华腔镜外科杂志(电子版), 2016, 9(6): 339-343. |
32. | 李士军, 刘家盛, 罗建飞. 袖状胃切除加空肠旁路术治疗肥胖症 37 例临床分析. 临床外科杂志, 2022, 30(6): 576-578. |
33. | Balasubaramaniam V, Pouwels S. Remission of type 2 diabetes mellitus (T2DM) after sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), and Roux-en-Y gastric bypass (RYGB): a systematic review. Medicina (Kaunas), 2023, 59(5): 985. |
34. | Elgenaied I, El Ansari W, Elsherif MA, et al. Factors associated with complete and partial remission, improvement, or unchanged diabetes status of obese adults 1 year after sleeve gastrectomy. Surg Obes Relat Dis, 2020, 16(10): 1521-1530. |
35. | Zhang H, Zhai Z, Cao K, et al. Short-term outcomes of sleeve gastrectomy plus uncut jejunojejunal bypass (SG-uncut JJB) in patients with obesity: a preliminary prospective cohort study. Langenbecks Arch Surg, 2023, 408(1): 9. |
36. | 李干斌, 翟志伟, 张皓宇, 等. 胃袖状切除加非离断空肠旁路术治疗肥胖症的近期疗效分析: 一项前瞻性队列研究. 中华胃肠外科杂志, 2022, 25(10): 906-912. |
37. | 梁辉, 林士波, 管蔚, 等. 单中心 4255 例减重代谢手术后早期严重并发症及其危险因素分析. 中华胃肠外科杂志, 2022, 25(10): 899-905. |
38. | Chen G, Zhang GX, Peng BQ, et al. Roux-En-Y gastric bypass versus sleeve gastrectomy plus procedures for treatment of morbid obesity: systematic review and meta-analysis. Obes Surg, 2021, 31(7): 3303-3311. |
39. | Angelini G, Salinari S, Castagneto-Gissey L, et al. Small intestinal metabolism is central to whole-body insulin resistance. Gut, 2021, 70(6): 1098-1109. |
40. | Strader AD, Vahl TP, Jandacek RJ, et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab, 2005, 288(2): E447-E453. |
41. | Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab, 2009, 35(6 Pt 2): 518-523. |
42. | Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg, 2006, 244(5): 741-749. |
43. | Rubino F, Marescaux J. Effect of duodenal-jejunal exclusionin a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg, 2004, 239(1): 1-11. |
44. | Larraufie P, Roberts GP, McGavigan AK, et al. Important role of the GLP-1 axis for glucose homeostasis after bariatric surgery. Cell Rep, 2019, 26(6): 1399-1408 e6. |
45. | Martinussen C, Bojsen-Møller KN, Dirksen C, et al. Augmented GLP-1 secretion as seen after gastric bypass may Be obtained by delaying carbohydrate digestion. J Clin Endocrinol Metab, 2019, 104(8): 3233-3244. |
46. | Zhong MW, Liu SZ, Zhang GY, et al. Effects of sleeve gastrectomy with jejuno-jejunal or jejuno-ileal loop on glycolipid metabolism in diabetic rats. World J Gastroenterol, 2016, 22(32): 7332-7341. |
47. | 刘勇, 马丹丹, 邵俊伟, 等. 胃袖状切除术联合空肠旁路术对 2 型糖尿病大鼠血糖及胰高血糖素样肽 1 表达的影响. 华南国防医学杂志, 2018, 32(9): 599-602. |
48. | Cheng Y, Huang X, Wu D, et al. Sleeve gastrectomy with bypass of proximal small intestine provides better diabetes control than sleeve gastrectomy alone under postoperative high-fat diet. Obes Surg, 2019, 29(1): 84-92. |
49. | Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes, 2006, 55(7): 2025-2031. |
50. | Jorsal T, Rhee NA, Pedersen J, et al. Enteroendocrine K and L cells in healthy and type 2 diabetic individuals. Diabetologia, 2018, 61(2): 284-294. |
51. | Kieffer TJ. GIP or not GIP? That is the question. Trends Pharmacol Sci, 2003, 24(3): 110-112. |
52. | Chen S, Okahara F, Osaki N, et al. Increased GIP signaling induces adipose inflammation via a HIF-1α dependent pathway and impairs insulin sensitivity in mice. Am J Physiol Endocrinol Metab, 2015, 308(5): E414-E425. |
53. | le Roux CW, Borg C, Wallis K, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg, 2010, 252(1): 50-56. |
54. | Ramracheya RD, McCulloch LJ, Clark A, et al. PYY-dependent restoration of impaired insulin and glucagon secretion in type 2 diabetes following Roux-En-Y gastric bypass surgery. Cell Rep, 2016, 15(5): 944-950. |
55. | Levan VH, Liddle RA, Green GM. Jejunal bypass stimulation of pancreatic growth and cholecystokinin secretion in rats: importance of luminal nutrients. Gut, 1987, 28(Suppl): 25-29. |
56. | Ma T, Huo S, Xu B, et al. A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice. Eur J Med Chem, 2020, 203: 112496. |
57. | Harris LLS, Smith GI, Mittendorfer B, et al. Roux-en-Y gastric bypass surgery has unique effects on postprandial FGF21 but not FGF19 secretion. J Clin Endocrinol Metab, 2017, 102(10): 3858-3864. |
58. | Wolf RM, Jaffe AE, Steele KE, et al. Cytokine, chemokine, and cytokine receptor changes are associated with metabolic improvements after bariatric surgery. J Clin Endocrinol Metab, 2019, 104(3): 947-956. |
59. | Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg, 2013, 23(11): 1922-1933. |
60. | Lauti M, Kularatna M, Hill AG, et al. Weight regain following sleeve gastrectomy-a systematic review. Obes Surg, 2016, 26(6): 1326-1334. |
61. | Suter M. Laparoscopic band repositioning for pouch dilatation/slippage after gastric banding: disappointing results. Obes Surg, 2001, 11(4): 507-512. |
62. | Yimcharoen P, Heneghan HM, Singh M, et al. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. Surg Endosc, 2011, 25(10): 3345-3352. |
63. | Heneghan HM, Yimcharoen P, Brethauer SA, et al. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis, 2012, 8(4): 408-415. |
64. | Amundsen T, Strømmen M, Martins C. Suboptimal weight loss and weight regain after gastric bypass surgery-postoperative status of energy intake, eating behavior, physical activity, and psychometrics. Obes Surg, 2017, 27(5): 1316-1323. |
65. | Çalık Başaran N, Dotan I, Dicker D. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels. Int J Obes (Lond), 2024, 15: 1-6. |
66. | Lin S, Li C, Shen J, et al. Loop versus Roux-en-Y duodenoje junal bypass with sleeve gastrectomy for type 2 diabetes: short term outcomes of a single-center randomized controlled trial. Surg Obes Relat Dis, 2022, 18(11): 1277-1285. |
67. | Tustumi F, Bernardo WM, Santo MA, et al. Cholecystectomy in patients submitted to bariatric procedure: a systematic review and meta-analysis. Obes Surg, 2018, 28(10): 3312-3320. |
68. | Lin S, Yang N, Guan W, et al. Can Chinese T2D patients with BMI 20-32. 5 kg/m2 benefit from loop duodenojejunal bypass with sleeve gastrectomy?. Surg Obes Relat Dis, 2019, 15(9): 1513-1519. |
69. | 姚立彬, 于英华, 李胜利, 等. 胃袖状切除术与胃袖状切除联合双通路术术后胃食管反流病对比研究. 中国实用外科杂志, 2024, 44(8): 911-915. |
70. | 朱孝成, 王键, 洪健, 等. 胃袖状切除联合双通路术对预防胃袖状切除术后胃食管反流病的价值. 中国实用外科杂志, 2024, 44(8): 880-884. |
71. | Hassn A, Luhmann A, Rahmani S, et al. Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery. Obes Surg, 2016, 26(10): 2316-2323. |
72. | Huang CK, Katakwar A. Sleeve plus procedures: need of time. Surg Today, 2020, 50(4): 419-422. |
73. | Raines D, Arbour A, Thompson HW, et al. Variation in small bowel length: factor in achieving total enteroscopy? . Dig Endosc, 2015, 27(1): 67-72. |
74. | 董光龙, 张频, 王勇, 等. 减重与代谢外科手术新术式及评价. 中国实用外科杂志, 2023, 43(5): 537-539. |
75. | Soong TC, Almalki OM, Lee WJ, et al. Measuring the small bowel length may decrease the incidence of malnutrition after laparoscopic one-anastomosis gastric bypass with tailored bypass limb. Surg Obes Relat Dis, 2019, 15(10): 1712-1718. |
76. | Wang A, Poliakin L, Sundaresan N, et al. The role of total alimentary limb length in Roux-en-Y gastric bypass: a systematic review. Surg Obes Relat Dis, 2022, 18(4): 555-563. |
77. | 牛牧天, 孟化, 胡扬喜, 等. 对称三孔法腹腔镜袖状胃切除术治疗原发性高血压的疗效分析. 腹腔镜外科杂志, 2022, 27(2): 90-95. |
78. | 中国人体健康科技促进会肥胖糖尿病主动健康专业委员会. 中国对称三孔法腹腔镜 Roux-en-Y 胃旁路术规范化手术操作指南(2023 版). 华西医学, 2023, 38(12): 1792-1800. |
79. | 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组. 中国肥胖及代谢疾病外科治疗指南(2024 版). 中国实用外科杂志, 2024, 44(8): 841-849. |
80. | 郭子豪, 刘昶. 腹腔镜袖状胃切除联合胃底折叠术对肥胖伴胃食管反流病的研究进展. 中国普外基础与临床杂志, 2023, 30(5): 635-640. |
81. | Pessorrusso F, Mehta SV, Sullivan S. Update on endoscopic treatments for obesity. Curr Obes Rep, 2024, 13(2): 364-376. |
- 1. Boutari C, Mantzoros CS. A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on. Metabolism, 2022, 133: 155217.
- 2. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet, 2024, 403(10431): 1027-1050.
- 3. Okunogbe A, Nugent R, Spencer G, et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health, 2022, 7(9): e009773.
- 4. GBD 2021 Risk Factors Collaborators. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet, 2024, 403(10440): 2162-2203.
- 5. Kloock S, Ziegler CG, Dischinger U. Obesity and its comorbidities, current treatment options and future perspectives: challenging bariatric surgery?. Pharmacol Ther, 2023, 251: 108549.
- 6. Brown WA, Liem R, Al-Sabah S, et al. Metabolic bariatric surgery across the IFSO chapters: key insights on the baseline patient demographics, procedure types, and mortality from the eighth IFSO global registry report. Obes Surg, 2024, 34(5): 1764-1777.
- 7. Biter LU, ’t Hart JW, Noordman BJ, et al. Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase Ⅲ multicentre randomised controlled trial (SleeveBypass). Lancet Reg Health Eur, 2024, 38: 100836.
- 8. Dang JT, Vaughan T, Mocanu V, et al. Conversion of sleeve gastrectomy to Roux-en-Y gastric bypass: indications, prevalence, and safety. Obes Surg, 2023, 33(5): 1486-1493.
- 9. Nielsen HJ, Nedrebø BG, Fosså A, et al. Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy. Int J Obes (Lond), 2022, 46(4): 739-749.
- 10. Kim JC, Kim MG, Park JK, et al. Outcomes and adverse events after bariatric surgery: an updated systematic review and meta-analysis, 2013-2023. J Metab Bariatr Surg, 2023, 12(2): 76-88.
- 11. 王涛, 师振, 于飞. 不同手术方案治疗重度肥胖合并 2 型糖尿病疗效比较. 新乡医学院学报, 2022, 39(4): 371-375.
- 12. Huang CK, Mahendra R, Hsin MC, et al. Novel metabolic surgery: first Asia series and short-term results of laparoscopic proximal jejunal bypass with sleeve gastrectomy. Ann Laparosc Endosc Surg, 2016, 1: 37.
- 13. 李梦伊, 刘雁军, 王桂琦, 等. 大中华减重与代谢手术数据库 2023 年度报告. 中国实用外科杂志, 2024, 44(5): 552-563, 570.
- 14. 中国医师协会外科医师分会肥胖和代谢病外科专家工作组, 中国医师协会外科医师分会肥胖代谢外科综合管理专家工作组, 中国肥胖代谢外科研究协作组. 中国肥胖代谢外科数据库: 2023 年度报告. 中华肥胖与代谢病电子杂志, 2024, 10(2): 73-83.
- 15. Lin S, Li C, Guan W, et al. Three-year outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective case-matched study with sleeve gastrectomy and gastric bypass in Chinese patients with BMI ≥35 kg/m2. Obes Surg, 2021, 31(8): 3525-3530.
- 16. Alamo Alamo M, Sepúlveda Torres C, Zapata Perez L. Vertical isolated gastroplasty with gastro-enteral bypass: preliminary results. Obes Surg, 2006, 16(3): 353-358.
- 17. de Menezes Ettinger JE, Azaro E, Mello CA, et al. Analysis of the vertical isolated gastroplasty: a new bariatric operation. Obes Surg, 2006, 16(9): 1261-1263.
- 18. Alamo M, Sepúlveda M, Gellona J, et al. Sleeve gastrectomy with jejunal bypass for the treatment of type 2 diabetes mellitus in patients with body mass index <35 kg/m2. A cohort study. Obes Surg, 2012, 22(7): 1097-1103.
- 19. 梁辉. 袖状胃切除加空肠旷置术的研究现状. 中华胃肠外科杂志, 2022, 25(10): 886-891.
- 20. Sridhar A, Khan D, Abdelaal M, et al. Differential effects of RYGB surgery and best medical treatment for obesity-diabetes on intestinal and islet adaptations in obese-diabetic ZDSD rats. PLoS One, 2022, 17(9): e0274788.
- 21. 罗衡桂, 唐彬, 毛岳峰, 等. 不同类型减重代谢手术治疗重度肥胖合并 2 型糖尿病的近期疗效分析. 中国普通外科杂志, 2020, 29(10): 1224-1233.
- 22. 梁辉, 李聪, 林士波, 等. 胃袖状切除术联合近端空肠旁路术与 Roux-en-Y 胃旁路术治疗 2 型糖尿病对照研究. 中国实用外科杂志, 2023, 43(5): 557-561.
- 23. 梁辉, 李聪, 沈佳佳. 胃袖状切除术附加手术术式选择及难点. 中国实用外科杂志, 2023, 43(5): 529-533.
- 24. Liang L, Gu R, Zheng R, et al. Comparative study of laparoscopic sleeve gastrectomy with or without jejunal bypass. Obes Surg, 2024, 34(8): 2888-2896.
- 25. 郑锐滨, 周霞, 赵象文. 超级肥胖的手术选择: 袖状胃切除术+空肠空肠旁路术?. 腹腔镜外科杂志, 2023, 28(10): 727-732.
- 26. 中国人体健康科技促进会肥胖糖尿病主动健康专业委员会. 中国对称三孔法腹腔镜胃袖状切除术规范化手术操作指南(2023 版). 华西医学, 2023, 38(12): 1785-1791.
- 27. Lin S, Guan W, Yang N, et al. Short-term outcomes of sleeve gastrectomy plus jejunojejunal bypass: a retrospective comparative study with sleeve gastrectomy and Roux-en-Y gastric bypass in Chinese patients with BMI ≥ 35 kg/m2. Obes Surg, 2019, 29(4): 1352-1359.
- 28. Sepúlveda M, Alamo M, Preiss Y, et al. Metabolic surgery comparing sleeve gastrectomy with jejunal bypass and Roux-en-Y gastric bypass in type 2 diabetic patients after 3 years. Obes Surg, 2018, 28(11): 3466-3473.
- 29. 刘山, 刘国栋, 胡鹏飞, 等. 中度肥胖患者行袖状胃切除与袖状胃切除联合空肠旁路术的短期效果对比分析. 腹腔镜外科杂志, 2023, 28(9): 664-669.
- 30. 刘浩, 赵稳, 武现生, 等. 40 kg/m2≤体重指数≤50 kg/m2 肥胖病人胃袖状切除联合空肠-空肠旁路术疗效的 2 年随访分析. 腹部外科, 2023, 36(5): 348-354.
- 31. 赵象文, 刘彦章, 梁銮盛, 等. 胃袖状切除加空肠旁路术在肥胖症的初步应用. 中华腔镜外科杂志(电子版), 2016, 9(6): 339-343.
- 32. 李士军, 刘家盛, 罗建飞. 袖状胃切除加空肠旁路术治疗肥胖症 37 例临床分析. 临床外科杂志, 2022, 30(6): 576-578.
- 33. Balasubaramaniam V, Pouwels S. Remission of type 2 diabetes mellitus (T2DM) after sleeve gastrectomy (SG), one-anastomosis gastric bypass (OAGB), and Roux-en-Y gastric bypass (RYGB): a systematic review. Medicina (Kaunas), 2023, 59(5): 985.
- 34. Elgenaied I, El Ansari W, Elsherif MA, et al. Factors associated with complete and partial remission, improvement, or unchanged diabetes status of obese adults 1 year after sleeve gastrectomy. Surg Obes Relat Dis, 2020, 16(10): 1521-1530.
- 35. Zhang H, Zhai Z, Cao K, et al. Short-term outcomes of sleeve gastrectomy plus uncut jejunojejunal bypass (SG-uncut JJB) in patients with obesity: a preliminary prospective cohort study. Langenbecks Arch Surg, 2023, 408(1): 9.
- 36. 李干斌, 翟志伟, 张皓宇, 等. 胃袖状切除加非离断空肠旁路术治疗肥胖症的近期疗效分析: 一项前瞻性队列研究. 中华胃肠外科杂志, 2022, 25(10): 906-912.
- 37. 梁辉, 林士波, 管蔚, 等. 单中心 4255 例减重代谢手术后早期严重并发症及其危险因素分析. 中华胃肠外科杂志, 2022, 25(10): 899-905.
- 38. Chen G, Zhang GX, Peng BQ, et al. Roux-En-Y gastric bypass versus sleeve gastrectomy plus procedures for treatment of morbid obesity: systematic review and meta-analysis. Obes Surg, 2021, 31(7): 3303-3311.
- 39. Angelini G, Salinari S, Castagneto-Gissey L, et al. Small intestinal metabolism is central to whole-body insulin resistance. Gut, 2021, 70(6): 1098-1109.
- 40. Strader AD, Vahl TP, Jandacek RJ, et al. Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab, 2005, 288(2): E447-E453.
- 41. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab, 2009, 35(6 Pt 2): 518-523.
- 42. Rubino F, Forgione A, Cummings DE, et al. The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg, 2006, 244(5): 741-749.
- 43. Rubino F, Marescaux J. Effect of duodenal-jejunal exclusionin a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg, 2004, 239(1): 1-11.
- 44. Larraufie P, Roberts GP, McGavigan AK, et al. Important role of the GLP-1 axis for glucose homeostasis after bariatric surgery. Cell Rep, 2019, 26(6): 1399-1408 e6.
- 45. Martinussen C, Bojsen-Møller KN, Dirksen C, et al. Augmented GLP-1 secretion as seen after gastric bypass may Be obtained by delaying carbohydrate digestion. J Clin Endocrinol Metab, 2019, 104(8): 3233-3244.
- 46. Zhong MW, Liu SZ, Zhang GY, et al. Effects of sleeve gastrectomy with jejuno-jejunal or jejuno-ileal loop on glycolipid metabolism in diabetic rats. World J Gastroenterol, 2016, 22(32): 7332-7341.
- 47. 刘勇, 马丹丹, 邵俊伟, 等. 胃袖状切除术联合空肠旁路术对 2 型糖尿病大鼠血糖及胰高血糖素样肽 1 表达的影响. 华南国防医学杂志, 2018, 32(9): 599-602.
- 48. Cheng Y, Huang X, Wu D, et al. Sleeve gastrectomy with bypass of proximal small intestine provides better diabetes control than sleeve gastrectomy alone under postoperative high-fat diet. Obes Surg, 2019, 29(1): 84-92.
- 49. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes, 2006, 55(7): 2025-2031.
- 50. Jorsal T, Rhee NA, Pedersen J, et al. Enteroendocrine K and L cells in healthy and type 2 diabetic individuals. Diabetologia, 2018, 61(2): 284-294.
- 51. Kieffer TJ. GIP or not GIP? That is the question. Trends Pharmacol Sci, 2003, 24(3): 110-112.
- 52. Chen S, Okahara F, Osaki N, et al. Increased GIP signaling induces adipose inflammation via a HIF-1α dependent pathway and impairs insulin sensitivity in mice. Am J Physiol Endocrinol Metab, 2015, 308(5): E414-E425.
- 53. le Roux CW, Borg C, Wallis K, et al. Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg, 2010, 252(1): 50-56.
- 54. Ramracheya RD, McCulloch LJ, Clark A, et al. PYY-dependent restoration of impaired insulin and glucagon secretion in type 2 diabetes following Roux-En-Y gastric bypass surgery. Cell Rep, 2016, 15(5): 944-950.
- 55. Levan VH, Liddle RA, Green GM. Jejunal bypass stimulation of pancreatic growth and cholecystokinin secretion in rats: importance of luminal nutrients. Gut, 1987, 28(Suppl): 25-29.
- 56. Ma T, Huo S, Xu B, et al. A novel long-acting oxyntomodulin analogue eliminates diabetes and obesity in mice. Eur J Med Chem, 2020, 203: 112496.
- 57. Harris LLS, Smith GI, Mittendorfer B, et al. Roux-en-Y gastric bypass surgery has unique effects on postprandial FGF21 but not FGF19 secretion. J Clin Endocrinol Metab, 2017, 102(10): 3858-3864.
- 58. Wolf RM, Jaffe AE, Steele KE, et al. Cytokine, chemokine, and cytokine receptor changes are associated with metabolic improvements after bariatric surgery. J Clin Endocrinol Metab, 2019, 104(3): 947-956.
- 59. Karmali S, Brar B, Shi X, et al. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg, 2013, 23(11): 1922-1933.
- 60. Lauti M, Kularatna M, Hill AG, et al. Weight regain following sleeve gastrectomy-a systematic review. Obes Surg, 2016, 26(6): 1326-1334.
- 61. Suter M. Laparoscopic band repositioning for pouch dilatation/slippage after gastric banding: disappointing results. Obes Surg, 2001, 11(4): 507-512.
- 62. Yimcharoen P, Heneghan HM, Singh M, et al. Endoscopic findings and outcomes of revisional procedures for patients with weight recidivism after gastric bypass. Surg Endosc, 2011, 25(10): 3345-3352.
- 63. Heneghan HM, Yimcharoen P, Brethauer SA, et al. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis, 2012, 8(4): 408-415.
- 64. Amundsen T, Strømmen M, Martins C. Suboptimal weight loss and weight regain after gastric bypass surgery-postoperative status of energy intake, eating behavior, physical activity, and psychometrics. Obes Surg, 2017, 27(5): 1316-1323.
- 65. Çalık Başaran N, Dotan I, Dicker D. Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels. Int J Obes (Lond), 2024, 15: 1-6.
- 66. Lin S, Li C, Shen J, et al. Loop versus Roux-en-Y duodenoje junal bypass with sleeve gastrectomy for type 2 diabetes: short term outcomes of a single-center randomized controlled trial. Surg Obes Relat Dis, 2022, 18(11): 1277-1285.
- 67. Tustumi F, Bernardo WM, Santo MA, et al. Cholecystectomy in patients submitted to bariatric procedure: a systematic review and meta-analysis. Obes Surg, 2018, 28(10): 3312-3320.
- 68. Lin S, Yang N, Guan W, et al. Can Chinese T2D patients with BMI 20-32. 5 kg/m2 benefit from loop duodenojejunal bypass with sleeve gastrectomy?. Surg Obes Relat Dis, 2019, 15(9): 1513-1519.
- 69. 姚立彬, 于英华, 李胜利, 等. 胃袖状切除术与胃袖状切除联合双通路术术后胃食管反流病对比研究. 中国实用外科杂志, 2024, 44(8): 911-915.
- 70. 朱孝成, 王键, 洪健, 等. 胃袖状切除联合双通路术对预防胃袖状切除术后胃食管反流病的价值. 中国实用外科杂志, 2024, 44(8): 880-884.
- 71. Hassn A, Luhmann A, Rahmani S, et al. Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery. Obes Surg, 2016, 26(10): 2316-2323.
- 72. Huang CK, Katakwar A. Sleeve plus procedures: need of time. Surg Today, 2020, 50(4): 419-422.
- 73. Raines D, Arbour A, Thompson HW, et al. Variation in small bowel length: factor in achieving total enteroscopy? . Dig Endosc, 2015, 27(1): 67-72.
- 74. 董光龙, 张频, 王勇, 等. 减重与代谢外科手术新术式及评价. 中国实用外科杂志, 2023, 43(5): 537-539.
- 75. Soong TC, Almalki OM, Lee WJ, et al. Measuring the small bowel length may decrease the incidence of malnutrition after laparoscopic one-anastomosis gastric bypass with tailored bypass limb. Surg Obes Relat Dis, 2019, 15(10): 1712-1718.
- 76. Wang A, Poliakin L, Sundaresan N, et al. The role of total alimentary limb length in Roux-en-Y gastric bypass: a systematic review. Surg Obes Relat Dis, 2022, 18(4): 555-563.
- 77. 牛牧天, 孟化, 胡扬喜, 等. 对称三孔法腹腔镜袖状胃切除术治疗原发性高血压的疗效分析. 腹腔镜外科杂志, 2022, 27(2): 90-95.
- 78. 中国人体健康科技促进会肥胖糖尿病主动健康专业委员会. 中国对称三孔法腹腔镜 Roux-en-Y 胃旁路术规范化手术操作指南(2023 版). 华西医学, 2023, 38(12): 1792-1800.
- 79. 中华医学会外科学分会甲状腺及代谢外科学组, 中国医师协会外科医师分会肥胖和代谢病外科专家工作组. 中国肥胖及代谢疾病外科治疗指南(2024 版). 中国实用外科杂志, 2024, 44(8): 841-849.
- 80. 郭子豪, 刘昶. 腹腔镜袖状胃切除联合胃底折叠术对肥胖伴胃食管反流病的研究进展. 中国普外基础与临床杂志, 2023, 30(5): 635-640.
- 81. Pessorrusso F, Mehta SV, Sullivan S. Update on endoscopic treatments for obesity. Curr Obes Rep, 2024, 13(2): 364-376.